MARIJUANA COMPANY OF AMERICA INC. (“MCOA” or the “Company”) (OTC: MCOA), an innovative hemp and cannabis corporation, is pleased to announce that the Company’s wholly owned subsidiary, hempSMART, Ltd., has successfully launched sales of the hempSMART™product line in the United Kingdom during the London event on March 23, 2019.
The hempSMART UK team successfully sold out its entire promotional inventory at the launch event, which led to over 1,000 new associates signing up with the Company’s associate networking program.
The official website of hempSMARTUK is live and can be visited at www.hempsmart.co.uk.
The event in London is being followed up by additional launch events taking place in Birmingham and Liverpool. Due to the success of our United Kingdom launch, the Company anticipates that the pre-launch for the hempSMART product line will take place in the Netherlands and Germany during Q2 2019.
Global Sales Director for hempSMART™, Ian Harvey, said,
“Our First Launch event was a huge success as we had to close registrations due to the hotel capacity being reached. To avoid disappointment, we have now scheduled two further launch events in Birmingham and Liverpool.
These events are filling fast and are both on track to be sold out despite booking larger venues. I was just nineteen when I first got involved in MLM and I have never experienced this level of excitement involving a launch.
With the next two venues filling up I truly believe that hempSMART™will become a household name across Europe very quickly.”
CEO of MCOA, Donald Steinberg, stated, “We are delighted to have launched our CBD product line hempSMART™internationally this past week. HempSMART™will continue to put in place the proper preparations to launch in additional EU countries moving forward.”
About Marijuana Company of America, Inc.
MCOA is a corporation which participates in: (1) product research and development of legal hemp-based consumer products under the brand name “hempSMART™”, that targets general health and well-being; (2) an affiliate marketing program to promote and sell its legal hemp-based consumer products containing CBD; (3) leasing of real property to separate business entities engaged in the growth and sale of cannabis in those states and jurisdictions where cannabis has been legalized and properly regulated for medicinal and recreational use; and, (4) the expansion of its business into ancillary areas of the legalized cannabis and hemp industry, as the legalized markets and opportunities in this segment mature and develop.
The United States Food and Drug Administration (FDA) has not recognized CBD as a safe and effective drug for any indication. Our products containing CBD derived from industrial hemp are not marketed or sold based upon claims that their use is safe and effective treatment for any medical condition as drugs or dietary supplements subject to the FDA’s jurisdiction.
Further, the marketing and sale of our hempSMART™products in the UK and EU, are not based upon claims that their use is a safe and effective treatment for any medical condition as drugs subject to the UK Medicines and Healthcare products Regulatory Agency (MHRA), or any similar EU regulatory agency. For more information please visit www.hempsmart.com
Get more information, facts and figures about HempSmart, click here for the HempSmart overview.